ACTRIMS/AAN
In this section
ACTRIMS/AAN ePosters
Catch-up with key data from selected ePosters at ACTRIMS/AAN 2023 by watching this series of expert discussions. Learn more about the following topics with data from patients with highly active relapsing multiple sclerosis (RMS) who received treatment with cladribine tablets, a high-efficacy disease modifying therapy (DMT):
- Dynamics of blood biomarkers, including B cells
- Cognitive function
- Stability of employment status
Blood biomarker dynamics in highly active RMS patients treated with cladribine tablets: Results of the 2-year MAGNIFY-MS study
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Catch up on the latest Merck-sponsored Industry Therapeutic Update from the 75th American Academy of Neurology (AAN) Annual Meeting, held in April 2023 in Boston, Massachusetts. Hear from experts in the field of multiple sclerosis (MS) as they reflect ‘Is it time to rethink MS?’, with coverage of the following topics:
- Is MS a disease continuum?
- The debate: does MS have one course?
- Addressing MS with novel markers and pathways
MS progression: is it a disease continuum?
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Watch this series of expert discussions on relapsing multiple sclerosis (RMS), covering key data presented at ACTRIMS 2022 and AAN 2022, to learn more about:
- Long-term disability outcomes after early high-efficacy disease-modifying therapies (DMT)
- Comparative efficacy and persistence of oral DMTs from real-world clinical data
- Latest data on treating MS
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
of interest
are looking at
saved
next event
Developed by EPG Health, for Medthority. This content has been developed in collaboration with Merck KGaA, Darmstadt, Germany. The materials shown in the webinar are intended for discussion purposes and must not be considered medical advice from a healthcare professional. EPG Health, received funding from Merck KGaA, Darmstadt, Germany in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. Any data on non-Merck KGaA, Darmstadt, Germany products are based on publicly available information at the time of content update. Prescribing information may vary depending on local health authority approval in each country. Before prescribing any product, always refer to the SmPC or product information approved in your local country.